These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 3593990

  • 1. Combined modality treatment of locally advanced breast cancer: adjuvant combination chemotherapy with and without doxorubicin.
    Casper ES, Guidera CA, Bosl GJ, Hakes TB, Kaufman RJ, Shurgot B, Kinne DW.
    Breast Cancer Res Treat; 1987; 9(1):39-44. PubMed ID: 3593990
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE, Green SJ, Lew D, Costanzi JJ, Athens JW, Osborne CK, Vaughn CB, Martino S.
    Cancer; 2003 Jan 01; 97(1):21-9. PubMed ID: 12491501
    [Abstract] [Full Text] [Related]

  • 3. Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study.
    Perloff M, Norton L, Korzun AH, Wood WC, Carey RW, Gottlieb A, Aust JC, Bank A, Silver RT, Saleh F, Canellos GP, Perry MC, Weiss RB, Holland JF.
    J Clin Oncol; 1996 May 01; 14(5):1589-98. PubMed ID: 8622076
    [Abstract] [Full Text] [Related]

  • 4. Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trial.
    Lichtman SM, Budman D, Bosworth H, Allen S, Schulman P, Weiselberg L, Weiss R, Lehrman D, Vinciguerra V.
    Am J Clin Oncol; 1991 Aug 01; 14(4):317-21. PubMed ID: 1907428
    [Abstract] [Full Text] [Related]

  • 5. Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.
    Aisner J, Cirrincione C, Perloff M, Perry M, Budman D, Abrams J, Panasci L, Muss H, Citron M, Holland J.
    J Clin Oncol; 1995 Jun 01; 13(6):1443-52. PubMed ID: 7751891
    [Abstract] [Full Text] [Related]

  • 6. Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study.
    Rivkin SE, Green S, Metch B, Glucksberg H, Gad-el-Mawla N, Constanzi JJ, Hoogstraten B, Athens J, Maloney T, Osborne CK.
    J Clin Oncol; 1989 Sep 01; 7(9):1229-38. PubMed ID: 2671283
    [Abstract] [Full Text] [Related]

  • 7. A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer. A Cancer and Leukemia Group B study.
    Tormey DC, Weinberg VE, Leone LA, Glidewell OJ, Perloff M, Kennedy BJ, Cortes E, Silver RT, Weiss RB, Aisner J.
    Am J Clin Oncol; 1984 Jun 01; 7(3):231-9. PubMed ID: 6375344
    [Abstract] [Full Text] [Related]

  • 8. Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study.
    Budd GT, Green S, O'Bryan RM, Martino S, Abeloff MD, Rinehart JJ, Hahn R, Harris J, Tormey D, O'Sullivan J.
    J Clin Oncol; 1995 Apr 01; 13(4):831-9. PubMed ID: 7707108
    [Abstract] [Full Text] [Related]

  • 9. CAP (cyclophosphamide, adriamycin, platinum) vs CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination chemotherapy in untreated metastatic breast cancer. A preliminary report of a controlled clinical study.
    Kolarić K, Roth A, Vukas D, Cervek J.
    Cancer Chemother Pharmacol; 1984 Apr 01; 13(2):142-4. PubMed ID: 6380789
    [Abstract] [Full Text] [Related]

  • 10. A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer.
    Smalley RV, Lefante J, Bartolucci A, Carpenter J, Vogel C, Krauss S.
    Breast Cancer Res Treat; 1983 Apr 01; 3(2):209-20. PubMed ID: 6688538
    [Abstract] [Full Text] [Related]

  • 11. Doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvant chemotherapy in breast cancer.
    Livi L, Saieva C, Borghesi S, De Luca Cardillo C, Scotti V, Mangoni M, Greto D, Cataliotti L, Paiar F, Bianchi S, Biti GP.
    J Chemother; 2009 Nov 01; 21(5):558-65. PubMed ID: 19933048
    [Abstract] [Full Text] [Related]

  • 12. Chemotherapy in advanced breast carcinoma. Comparison between doxorubicin-cyclophosphamide and cyclophosphamide-methotrexate-5-fluorouracil-vincristine-prednisone.
    Parvinen LM, Numminen S.
    Acta Radiol Oncol; 1985 Nov 01; 24(5):391-4. PubMed ID: 3002135
    [Abstract] [Full Text] [Related]

  • 13. Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone.
    Pinnamaneni K, Yap HY, Buzdar AU, Distefano A, Blumenschein GR.
    Cancer; 1984 May 01; 53(9):1841-4. PubMed ID: 6546706
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer--a randomised study with more than 10 years follow-up from the Danish Breast Cancer Cooperative Group. Danish Breast Cancer Cooperative Group (DBCG).
    Andersson M, Madsen EL, Overgaard M, Rose C, Dombernowsky P, Mouridsen HT.
    Eur J Cancer; 1999 Jan 01; 35(1):39-46. PubMed ID: 10211086
    [Abstract] [Full Text] [Related]

  • 20. A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.
    Bennett JM, Muss HB, Doroshow JH, Wolff S, Krementz ET, Cartwright K, Dukart G, Reisman A, Schoch I.
    J Clin Oncol; 1988 Oct 01; 6(10):1611-20. PubMed ID: 3049953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.